BACKGROUND: The use of tyrosine kinase inhibitors to target the epidermal growth factor receptor gene (EGFR) in patients with non-small-cell lung cancer is effective but limited by the emergence of drug-resistance mutations. Molecular characterization of circulating tumor cells may provide a strateg...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!